Contribution Of Nuclear Magnetic Resonance Imaging In The Study Of Diabetic Cardiomyopathy

NCT ID: NCT01295385

Last Updated: 2015-04-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-02-28

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diagnosis of diabetic cardiomyopathy is then retained, supposing a change in the coronary microcirculation linked to an endothelial dysfunction. Abnormalities of the myocardial metabolism is frequently associated. It is regrettably about a hypothesis difficult to verify with current medical techniques.This deficiency being not only harmful to the diagnosis, but also to the assessment of the efficiency of the medical treatment on the myocardial metabolism and the endothelial function. Techniques of nuclear magnetic resonance offer interesting perspectives.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

These techniques allow in this context:

1. to quantify the myocardial blood flow at rest and after "cold pressor test" in a population of healthy volunteers. The myocardial blood flow will be obtained by estimating myocardial blood flow at the venous coronary sinus site. This allows us to quantify a possible endothelial dysfunction in a reproducible way. No MRI study in diabetic patients has ever been led until now with this technique.
2. to estimate the metabolic and structural abnormalities in this population, with particularly:

* Quantification of the myocardial metabolism in vivo by spectrometry of phosphorus 31.
* Structural abnormalities: become integrated into the description of diabetic cardiomyopathy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Cardiomyopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

healthy volunteers

Group Type EXPERIMENTAL

NUCLEAR MAGNETIC RESONANCE IMAGING

Intervention Type OTHER

Techniques of nuclear magnetic resonance offer interesting perspectives in this context, and particularly to quantify the myocardial blood flow at rest and after "cold pressor test" in a population of healthy volunteers.

patients with a diabetic cardiomyopathy

Group Type ACTIVE_COMPARATOR

NUCLEAR MAGNETIC RESONANCE IMAGING

Intervention Type OTHER

Techniques of nuclear magnetic resonance offer interesting perspectives in this context, and particularly to quantify the myocardial blood flow will be obtained by estimating myocardial blood flow at the venous coronary sinus site. This allows us to quantify a possible endothelial dysfunction in a reproducible way. No MRI study in diabetic patients has ever been led until now with this technique and to estimate the metabolic and structural abnormalities in this population.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NUCLEAR MAGNETIC RESONANCE IMAGING

Techniques of nuclear magnetic resonance offer interesting perspectives in this context, and particularly to quantify the myocardial blood flow at rest and after "cold pressor test" in a population of healthy volunteers.

Intervention Type OTHER

NUCLEAR MAGNETIC RESONANCE IMAGING

Techniques of nuclear magnetic resonance offer interesting perspectives in this context, and particularly to quantify the myocardial blood flow will be obtained by estimating myocardial blood flow at the venous coronary sinus site. This allows us to quantify a possible endothelial dysfunction in a reproducible way. No MRI study in diabetic patients has ever been led until now with this technique and to estimate the metabolic and structural abnormalities in this population.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* more than 18 years old
* patient type 2 diabetes affects taken care more than 5 years to Timone Hospital
* patient with a diabetic cardiomyopathy
* informed and consented

Exclusion Criteria

* less than 18 years
* Pregnant woman
* patient type 1 diabetes affects
* patient presents a cardiomyopathy mixed (no diabetic)
* patients presents an arrhythmia ventriculaire or above - ventriculaire
* Unstable hémodynamique patients
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique Hopitaux De Marseille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jacques Quilici, Doctor

Role: PRINCIPAL_INVESTIGATOR

APHM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assistance Publique - Hopitaux de Marseille

Marseille, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jacques Quilici, Doctor

Role: CONTACT

+33491385973

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jacques Quilici, Doctor

Role: primary

+33491385973

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009-41

Identifier Type: -

Identifier Source: secondary_id

2010-A00233-36

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CMR in T2DM: The NSR Cohort
NCT05915260 ENROLLING_BY_INVITATION